BioSyent Inc. (TSXV: RX)

BioSyent Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	12.78	7.98	7.86	18.04	20.29	13.44
Short-Term Investments	4.28	18.2	20.83	10.18	5.29	8.53
Cash & Short-Term Investments	17.06	26.19	28.7	28.21	25.58	21.97
Cash Growth	-41.74%	-8.74%	1.72%	10.30%	16.40%	-10.04%
Accounts Receivable	4.34	3.45	3.18	2.49	1.6	1.81
Other Receivables	-	0.03	0.32	0.29	0.22	0.27
Receivables	4.41	3.55	3.66	3.21	1.82	2.08
Inventory	5.66	5.89	4.54	2.2	2.07	2.14
Prepaid Expenses	0.39	0.24	0.25	0.46	0.31	0.65
Other Current Assets	0.02	-	-	-	-	-
Total Current Assets	27.55	35.87	37.14	34.08	29.77	26.85
Property, Plant & Equipment	1.25	1.4	1.61	1.85	2.07	2.36
Long-Term Investments	10.5	2.5	-	-	-	-
Other Intangible Assets	5.71	1.02	1.09	0.83	0.96	1.08
Long-Term Deferred Tax Assets	0.3	0.36	0.21	0.1	0.03	0.03
Long-Term Deferred Charges	-	0.17	0.17	0.12	0.13	0.07
Total Assets	45.47	41.53	40.49	37.17	33.57	30.97
Accounts Payable	6.25	5.08	5.06	3.56	3.72	2.92
Current Portion of Leases	0.19	0.18	0.17	0.16	0.15	0.14
Current Income Taxes Payable	0.25	0.11	0.32	0.1	0.25	0.15
Current Unearned Revenue	0.34	0.13	0.16	0.31	0.93	0.1
Other Current Liabilities	-	0.03	-	-	0.08	0.04
Total Current Liabilities	7.03	5.53	5.72	4.14	5.14	3.36
Long-Term Leases	0.89	1.04	1.22	1.4	1.56	1.71
Long-Term Deferred Tax Liabilities	0.2	0.2	0.18	0.08	0.08	0.1
Total Liabilities	8.12	6.77	7.12	5.61	6.78	5.17
Common Stock	5.14	5.12	5.37	5.8	6.39	7.18
Additional Paid-In Capital	2.15	2.29	2.23	1.82	1.49	1.24
Retained Earnings	30.26	27.53	25.91	24.12	19.08	17.48
Comprehensive Income & Other	-0.2	-0.18	-0.14	-0.19	-0.17	-0.11
Shareholders' Equity	37.35	34.76	33.36	31.55	26.8	25.79
Total Liabilities & Equity	45.47	41.53	40.49	37.17	33.57	30.97
Total Debt	1.08	1.22	1.4	1.56	1.71	1.85
Net Cash (Debt)	15.98	24.97	27.3	26.65	23.87	20.12
Net Cash Growth	-42.98%	-8.55%	2.42%	11.67%	18.63%	-17.62%
Net Cash Per Share	1.34	2.05	2.18	2.07	1.82	1.44
Filing Date Shares Outstanding	11.59	11.61	12.1	12.41	12.74	13.41
Total Common Shares Outstanding	11.59	11.74	12.1	12.56	12.81	13.53
Working Capital	20.52	30.34	31.42	29.94	24.64	23.49
Book Value Per Share	3.22	2.96	2.76	2.51	2.09	1.91
Tangible Book Value	31.64	33.74	32.27	30.72	25.83	24.72
Tangible Book Value Per Share	2.73	2.87	2.67	2.45	2.02	1.83
Machinery	-	0.91	0.85	0.81	0.75	0.74
Leasehold Improvements	-	0.68	0.68	0.68	0.68	0.68

Source: S&P Capital IQ. Standard template. Financial Sources.